Durable growth in retirement and insurance markets | Transcript


Joe Coletti: Welcome to Innovators and Ideas, an interview series from RBC Capital Markets, where we explore bold thinking and impactful leadership shaping the future of the financial sector today. I’m your host, Joe Coletti. Today we’re at RBC’s Global Financial Institutions conference here in New York, and I’m joined by Paul McDonough, CFO of CNO Financial Group, a company providing life and health insurance, annuities and financial services to middle income Americans through a portfolio of specialized brands.

Paul, thanks for joining us today.

Paul McDonough: Thank you, Joe. It's my pleasure. Appreciate the opportunity.

Joe Colletti: So CNO is focused on serving middle income Americans as they plan for retirement. Last year, we spoke with your CEO, talked about your strategic direction, your growth priorities. From your vantage point as CFO, what has changed since last year? Has anything evolved? But also what has changed the most since then?

Paul McDonough: Sure. Well, certainly, the macroeconomic and geopolitical landscape has changed quite a bit in the last year. Our strategic direction and our priorities really have not changed in the last year or even the last several years. Dating back to when we formed the consumer division and worksite division in 2020 our strategic focus has been really stable and consistent. Our mission at CNO is to secure the future of middle income America by providing insurance and other financial services to protect their health, income, and retirement needs. We distribute a wide range of products, life annuity and health products, and provide broader financial planning through our exclusive agents, primarily under the Bankers Life brand, the Optimize brand. We also distribute through a direct-to-consumer channel. And then lastly, we distribute selectively through independent partners. Our focus on middle income households, together with our broad distribution and product set, gives us a very differentiated business model relative to our peer group, and creates a competitive moat that is very difficult to either penetrate or duplicate. We also benefit from a significant demographic tailwind in that every day, roughly 11,000 Americans turn 65. And when they do, they're they become eligible for Medicare, and they're faced with navigating the fairly complex and to some degree confusing set of choices around Medicare. And our agents are uniquely qualified to help customers navigate those choices. Through their training, they help prospective clients understand Medicare, Medicare Supplement, which we manufacture and distribute, Medicare Advantage, which we distribute for third parties. And very often, those conversations, over time, lead to a broader discussion around their more holistic retirement planning needs. We also benefit from two other secular tailwinds. The first is the emergence of major medical plans with very high deductibles, and that creates a need for supplemental health insurance products, which we manufacture and distribute. And the second is the demise of defined benefit plans and the reliance on defined contribution plans, which increases the risk for individuals, particularly middle income and lower income individuals, that they will outlive their savings, and that dynamic creates a need for the guaranteed income feature of annuities, which we manufacture and distribute, the partial sort of safety net of long term care insurance, which we also manufacture and distribute. And the combination of our focus on middle income households and the way that we're positioned to serve middle income households across our products and distribution channels creates a very significant and continuing growth opportunity for us.

Joe Colletti: So you've described CNO’s performance as consistent and repeatable. What specifically makes that durability structural rather than cyclical, especially given the volatility across the industry?

Paul McDonough: So, I don't think the insurance industry, the life and health insurance industry, is all that volatile compared to other industries, certainly not, we're not immune to volatility, but given the fact that it's highly regulated and given the fairly stable demand for our products, I don't view it to be all that volatile. Having said that, to your question, I do believe that our results are durable and structural rather than cyclical, and will persist through the business cycle and credit cycles is just the fact that we have a differentiated business model, and combining that with just the strength of our team, both in the field and in the home office. Ultimately, the proof is in the results. I think it's fair to say that we've developed a reputation for delivering against the expectations that we've created for ourselves. In the wake of covid 19, over the last three years, we've generated very consistent quarterly sales growth. In 2025 we hit a number of sales records across our product portfolio, life annuities and health and across both our consumer and work site divisions. We also hit record levels of assets in our broker dealer and advisory. Importantly, we also achieved or exceeded all of the earnings related guidance metrics that we provided at the beginning of 2025 and investors have taken notice. We hit a number of record highs in our stock price during 2025, again in February of 2026. And over the three year period from ‘23 to the end of 2025, our stock price nearly doubled, and we ranked second in total shareholder return in a peer group of 12 companies.

Joe Colletti: You really sit at the intersection of strategy, capital and risk, and so what do you think the most important things are when it comes to navigating not just the changing macroeconomic cycles, but continuing to position yourself for that long term growth at the same time?

Paul McDonough: So I think most important is a differentiated business model and an effective leadership team. In addition, I think it's important to have a healthy and dynamic risk management culture. I think we have a enterprise risk management framework that is very mature and includes an efficient and effective governance structure, so beginning with the board, and cascading down from there, coordinated risk assessment across our enterprise risk management team, our internal audit team and the compliance function in our legal team, a well-defined risk appetite, a clear understanding of how much capital is required to both support growth and to absorb stress events and tail type scenarios, and then, importantly, a culture of engagement and open dialog around risk throughout the organization. So our diverse product offering, life annuity, health, diversifies our risk relative to the underlying risks of mortality, morbidity and longevity. And as a result, we tend to have puts and takes across those underlying risks and across our products in terms of our claims experience and insurance product margin. Although one product might be favorable or unfavorable in any given period, in total, the margin is relatively stable, and then the diversification across distribution channels results in less volatility in sales. So the net is that we have a differentiated business model, and one of the benefits of that is it reduces our risk.

Joe Coletti: So your run rate operating ROE, or return on equity, has been improving over the last several years. Can you talk about some of the big drivers behind those improvements, but also, how does it reflect the way that you're balancing growth, profitability and risk?

Paul McDonough: Sure. So maybe just to provide a little context on the ROE. We have an ROE that's at the low end of our peer group, and that's really a function of where we are in our evolution as a company. So coming out of bankruptcy in 2003 really focused on sort of cleaning up the balance sheet, de-risking the balance sheet, really through to about 2018, and then from that point forward, pivoting to growth. And so in ‘24, ’25 we began to pivot not to just sales growth, but also sales and earnings growth. And improved ROE. And in the beginning of 2025 we shared a three year goal of improving the run rate return on equity by 150 basis points off of a run rate of about 10% in 2024. And then in the fourth quarter of last year, ’25, we added 50 basis points to that, so 200 basis points of improvement in the ’25 to ‘27 period. So a goal of 12% in 2027. That's not an end point, to be clear, it's an initial goal. Our long term goal is to get to top quartile ROE relative to our peer group. We've made good progress. In 2025 we generated an 11.4% operating ROE. So now to your question, what's driving that? And there really have been no silver bullets, there's not one thing that's really driven it, but rather, it's a series of factors and initiatives across the value chain, and importantly, beginning with sales growth, which translates to earnings growth, which provides better operating leverage. But beyond that, expense discipline, capital discipline, being very thoughtful about product development, including product pricing and investment management. So I view those as sort of the primary buckets. Within expenses we've been very deliberate in our planning and execution to improve efficiency and effectiveness, both internally and outsourcing certain activities where there's value there. We've invested in technology, both internally and through our partners, including AI and robotics, more recently, in agentic AI. And that's in its early stages. On the capital front, we established an affiliated Bermuda reinsurance company in ‘23 and have ceded some of our liabilities through two treaties now to the Bermuda company, enhancing our capital structure and positioning ourselves to serve our policy holders more effectively. We also are careful to adjust our sources of capital, debt and equity to maintain an optimal level of debt to total capital. On the product development side, we have a team of actuaries that I think have been very successful in developing products that meet the needs of our customers and also hit our target returns through thoughtful pricing. And then lastly, on the investment management side, we have a very seasoned team of investment professionals that have a very impressive track record of generating consistent risk-adjusted returns. We manage most of it internally. We do outsource selectively to third parties in certain asset classes, for example, private equity, private credit and, real estate.

Joe Colletti: So you mentioned you're making investments in technology and AI, obviously analytics. And want to talk, AI and advanced analytics in particular are really reshaping customer engagement, operations. From a financial leadership lens, where do you see the greatest opportunity to drive more productivity, more efficiency, but also margin expansion?

Paul McDonough: So, as I mentioned, we've been investing in AI and robotics, really, for years – that what's new is agentic AI. The biggest impact, initially, is in coding efficiencies. I'm sure you've seen and heard a lot about that. We're capturing efficiencies there's both internally and with our outsource partners. So that's been the biggest early win. Beyond that, we've deployed various use cases, both employee facing and customer facing, and most notably call answering and chat in customer services and our final expense, life insurance product, intelligent document processing across our product portfolio. And those things have translated to some real savings which contribute to earnings growth. And, you know, there's a long list of use cases that are in various stages of ideation and experimentation and deployment. There's solid governance around that in terms of prioritization. So far, this has been mostly a bottoms-up process. We're beginning to pivot to think about, how do we manage it from top down as well? I do think that agentic AI will impact, really every stage of the value chain and the business model. I think it's going to become table stakes in terms of how businesses operate in a space. We think and our advisors tell us that we're ahead of the curve a bit relative to our peers, but I don't think in the long run, it's something that is differentiating, but something that, again, to compete effectively, you'll have to successfully leverage this technology. We do not think, I would just say, as a final point, we do not think agentic AI replaces human beings, particularly in the field, at the point of sale with clients, because you think about just the inherent complexity of life, annuity, health products, and the emotional component, it's all about health and mortality. People don't just wake up thinking to buy these, takes some education. So in that context, we think human beings remain a critical component of the business model.

Joe Coletti: Yeah, you mentioned earlier, share price hit record highs and back in February. How do you interpret that internally, as you think about your strategy and execution moving forward?

Paul McDonough: Yeah, it's nice to see, certainly. And I think it's a reflection of the sales growth and earnings growth and ROE improvement that we've delivered. Certainly, I think it's a vote of confidence in the strategic direction of the company and the management team, and as I think about where we go from here, our expectation is that we continue to drive ROE improvement, and that ROE improvement will support continued top-quartile total shareholder return against our peer group.

Joe Coletti: It’s been a pleasure. We learned a lot about the company.

Paul McDonough: Thank you again. Appreciate it.

Joe Coletti: Have a great conference.

Paul McDonough: You too.

[OUTRO]

Joe Coletti: Thanks for listening to Innovators and Ideas, an interview series from RBC Capital Markets. This episode was recorded on March 11, 2026. If you’d like to learn more about the topics discussed in this episode or continue the conversation, please visit rbccm.com/insights, or contact your RBC representative. See you all next time.

This content is based on information available at the time it was recorded, and is for informational purposes only. It is not an offer to buy or sell or a solicitation, and no recommendations are implied. It is outside the scope of this communication to consider whether it is suitable for you and your financial objectives.